Abbott Laboratories (NYSE:ABT) reported on Friday that its board of directors authorised a common stock dividend of USD0.45 per share for the quarter, the company .
This 389th consecutive quarterly dividend will be paid on 17 May 2021 to shareholders of record at the close of business on 15 April 2021.
Also, the company said it has paid dividends since 1924 and increased its dividend payout for 49 consecutive years.
Abbott discovers, develops, manufactures and sells health care products worldwide. It operates through the Established Pharmaceutical Products segment; Diagnostic Products segment; and Medical Devices segment. It has an agreement with Tandem Diabetes Care to develop and commercialise integrated diabetes solutions.
The company was founded in 1888 and is headquartered in North Chicago, Illinois, USA.
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return